Techie News
Genetic Engineering & Biotechnology News
A combination cancer treatment of AstraZeneca's Phase III immuno-oncology treatment candidate MEDI4736 and Eli Lilly's marketed product Cyramza® (ramucirumab) will be assessed in patients with advanced solid tumors under a Phase I clinical trial ...
Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical ... CNNMoney
AstraZeneca and Lilly collaborate on cancer drug combo Seeking Alpha
Rate this item The FINANCIAL
FiercePharma -Yahoo News
all 25 news articles »
from @ Health and Medical News http://ift.tt/1EE3KYr
via Health and Medical NewsHealth and Medical News Pfizer Inc has already had its takeover overtures rebuffed three times by rival AstraZeneca Plc, but investors in the U.S. drugmaker say it can tolerate a little more rejection before going hostile with the deal. AstraZeneca turned down a sweeten...
